Similar articles for PMID: 21980039

Year	Number of Results
1992	1
1993	1
1994	2
1996	5
1997	8
1998	5
1999	5
2000	9
2001	3
2002	6
2003	1
2004	3
2005	5
2006	2
2007	4
2008	1
2009	7
2010	5
2011	5
2012	4
2015	2
2016	1
2017	1
2018	2
2019	4
2020	3
2021	2
2022	1

1

Timing of ganciclovir administration in glioma gene therapy using HSVtk gene-transduced mesenchymal stem cells.

Amano S, Gu C, Koizumi S, Tokuyama T, Namba H. Amano S, et al. Cancer Genomics Proteomics. 2011 Sep-Oct;8(5):245-50. Cancer Genomics Proteomics. 2011. PMID: 21980039

2

Tumoricidal bystander effect in the suicide gene therapy using mesenchymal stem cells does not injure normal brain tissues.

Amano S, Gu C, Koizumi S, Tokuyama T, Namba H. Amano S, et al. Cancer Lett. 2011 Jul 1;306(1):99-105. doi: 10.1016/j.canlet.2011.02.037. Epub 2011 Mar 29. Cancer Lett. 2011. PMID: 21450400

3

Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells.

Li S, Tokuyama T, Yamamoto J, Koide M, Yokota N, Namba H. Li S, et al. Cancer Gene Ther. 2005 Jul;12(7):600-7. doi: 10.1038/sj.cgt.7700826. Cancer Gene Ther. 2005. PMID: 15775995

4

Therapeutic effect of genetically engineered mesenchymal stem cells in rat experimental leptomeningeal glioma model.

Gu C, Li S, Tokuyama T, Yokota N, Namba H. Gu C, et al. Cancer Lett. 2010 May 28;291(2):256-62. doi: 10.1016/j.canlet.2009.10.020. Epub 2009 Nov 27. Cancer Lett. 2010. PMID: 19945214

5

Use of genetically engineered bone marrow-derived mesenchymal stem cells for glioma gene therapy.

Amano S, Li S, Gu C, Gao Y, Koizumi S, Yamamoto S, Terakawa S, Namba H. Amano S, et al. Int J Oncol. 2009 Dec;35(6):1265-70. doi: 10.3892/ijo_00000443. Int J Oncol. 2009. PMID: 19885548

6

Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.

Namba H, Tagawa M, Miyagawa T, Iwadate Y, Sakiyama S. Namba H, et al. Cancer Gene Ther. 2000 Jun;7(6):947-53. doi: 10.1038/sj.cgt.7700172. Cancer Gene Ther. 2000. PMID: 10880027

7

Suicide Gene Therapy Against Malignant Gliomas by the Local Delivery of Genetically Engineered Umbilical Cord Mesenchymal Stem Cells as Cellular Vehicles.

Wei D, Hou J, Zheng K, Jin X, Xie Q, Cheng L, Sun X. Wei D, et al. Curr Gene Ther. 2019;19(5):330-341. doi: 10.2174/1566523219666191028103703. Curr Gene Ther. 2019. PMID: 31657679

8

Genetically engineered neural stem cells migrate and suppress glioma cell growth at distant intracranial sites.

Li S, Gao Y, Tokuyama T, Yamamoto J, Yokota N, Yamamoto S, Terakawa S, Kitagawa M, Namba H. Li S, et al. Cancer Lett. 2007 Jun 28;251(2):220-7. doi: 10.1016/j.canlet.2006.11.024. Epub 2006 Dec 28. Cancer Lett. 2007. PMID: 17196326

9

Suicide gene therapy of human breast cancer in SCID mice model by the regulation of Tet-On.

Hu WX, Zeng ZJ, Luo SQ, Chen Q. Hu WX, et al. Chin Med J (Engl). 2004 Mar;117(3):434-9. Chin Med J (Engl). 2004. PMID: 15043787

10

In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.

Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K. Okada T, et al. J Gene Med. 2004 Mar;6(3):288-99. doi: 10.1002/jgm.490. J Gene Med. 2004. PMID: 15026990

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed